Globus Medical (GMED) Enterprise Value (2011 - 2026)

Globus Medical has reported Enterprise Value for 16 years, with the latest figure at -$629.9 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 36.55% year-over-year to -$629.9 million; the trailing twelve-month figure through Mar 2026 stood at -$629.9 million (down 36.55% YoY), and the FY2025 full-year result was -$557.2 million, up 37.39% from the prior year.
• Enterprise Value for Q1 2026 stood at -$629.9 million, down from -$557.2 million in the prior quarter.
• The five-year high for Enterprise Value was -$229.4 million in Q2 2025, with the low at -$890.1 million in Q4 2024.
• Historically, Enterprise Value has averaged -$506.9 million across 5 years, with a median of -$473.3 million in 2022.
• Annual changes were most pronounced in 2024 — Enterprise Value plunged 71.9% — and 2025, when it jumped 53.45%.
• Globus Medical's Enterprise Value stood at -$446.1 million in 2022, then declined by 16.08% to -$517.8 million in 2023, then sank by 71.9% to -$890.1 million in 2024, then surged by 37.39% to -$557.2 million in 2025, then retreated by 13.03% to -$629.9 million in 2026.
• The last three Enterprise Value figures came in at -$629.9 million (Q1 2026), -$557.2 million (Q4 2025), and -$390.5 million (Q3 2025), per Business Quant data.